Wang Mark S MS - OmicsDI

Show results for

Genomics (56)
Unknown (48)
Proteomics (38)
Metabolomics (10)
Transcriptomics (9)

Organisms

Homo sapiens (36)
Andropogon gerardi (26)
Bacteria (26)
Bartonella quintana JK 31 (26)
Canis lupus familiaris (26)
Clavibacter nebraskensis NCPPB 2581 (26)
Cnidaria (26)
Ensifer adhaerens (26)
Human alphaherpesvirus 1 strain 17 (26)
Human alphaherpesvirus 1 strain KOS (26)
Human betaherpesvirus 5 (26)
Human herpesvirus 2 strain 186 (26)
Mesocricetus auratus (26)
Miscanthus x giganteus (26)
Mus musculus (26)
Panicum virgatum (26)
Platyhelminthes (26)
Pseudomonas aeruginosa PA103 (26)
Rabies virus Nishigahara RCEH (26)
Rattus norvegicus (26)
Rattus rattus (26)
Rhodococcus jostii RHA1 (26)
Rhodopseudomonas palustris (26)
Shigella (26)
Caenorhabditis elegans (22)
Arabidopsis thaliana (3)
Mus musculus (3)
Saccharomyces cerevisiae (3)
Taeniopygia guttata (1)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (38)
EGA (27)
pride (26)
MetaboLights (9)
MassIVE (8)
PeptideAtlas (2)
GNPS (1)
iProX (1)
PanoramaPublic (1)

Tissue

Cell culture (8)
Early embryonic cell (6)
Permanent cell line cell (3)
Blood plasma (2)
Heart (2)
Testis (2)
Adipose tissue (1)
Bile (1)
Bile duct (1)
Blood serum (1)
Blood-lymph (1)
Bone marrow (1)
Brain (1)
Colon (1)
Epithelial cell (1)
Hepatocyte (1)
Kidney (1)
Liver (1)
Lung (1)
Lymph node (1)
Muscle (1)
Pancreas (1)
Prostate cancer cell line (1)
Seedling (1)
Skin (1)
Subcutaneous abdominal adipose tissue (1)

Disease

Disease free (4)
Acute leukemia (1)
Brain cancer (1)
COVID-19 (1)
Childhood extraosseous osteosarcoma (1)
Cholangiocarcinoma (1)
Chronic bronchitis (1)
Colon cancer (1)
Embryonal rhabdomyosarcoma (1)
Fibrosarcoma (1)
Head and neck cancer (1)
Lung carcinoma (1)
Malignant mesothelioma (1)
Melanoma (1)
Neuroblastoma (1)
Pancreatic cancer (1)
Peripheral primitive neuroectodermal tumor (1)
Prostate adenocarcinoma (1)
Renal Wilms' tumor (1)
Retinoblastoma (1)
Stomach cancer (1)
Synovial sarcoma (1)
Type 2 diabetes mellitus (1)
Uveal melanoma (1)

Technology Type

Mass Spectrometry (26)
Shotgun proteomics (16)
Mass spectrometry (8)
Affinity purification coupled with mass spectrometry proteomics (3)
Data-dependent acquisition (3)
Data-independent acquisition (3)
Gel-based experiment (3)
Bottom-up proteomics (2)
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0 (1)
NMR spectroscopy (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Immunopeptidomics (1)
SRM/MRM (1)

Instrument Platform

Orbitrap Fusion Lumos (3)
Liquid Chromatography MS - positive - reverse phase (3)
LTQ Orbitrap (2)
Tandem Gas Chromatography MS - (2)
LECO Pegasus 4D (2)
LTQ (2)
G2565BA DNA microarray scanner [Agilent] (1)
Scanning hardware (1)
LTQ Orbitrap Elite (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion (1)
Q Exactive (1)
TimsTOF Pro (1)
Xevo G2-S QTof (1)
Flow injection analysis MS - (1)
Tandem Gas Chromatography MS - positive (1)
Bruker (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2011 (24)
2023 (10)
2010 (6)
2025 (6)
2021 (5)
2022 (4)
2020 (4)
2024 (4)
2007 (3)
2026 (3)
2016 (2)
2008 (2)
2014 (2)
2015 (2)
2006 (2)
2018 (2)
2013 (1)
2009 (1)
2019 (1)

UNIPROT ID/AC

P06208-2 (2)
P07263-2 (2)
P21269-3 (2)
P38431-2 (2)
Q12337 (2)
R0020C (2)
Q01532 (1)

CHEBI ID

CHEBI:30746 (5)
CHEBI:28842 (5)
CHEBI:17148 (5)
CHEBI:17115 (5)
CHEBI:17568 (5)
CHEBI:16695 (5)
CHEBI:30797 (5)
CHEBI:17345 (5)
CHEBI:15428 (5)
CHEBI:17053 (5)
CHEBI:15756 (5)
CHEBI:30769 (5)
CHEBI:29019 (4)
CHEBI:84271 (4)
CHEBI:32941 (4)
CHEBI:84249 (4)
CHEBI:84222 (4)
CHEBI:55381 (4)
CHEBI:16988 (4)
CHEBI:33118 (4)
CHEBI:17754 (4)
CHEBI:16000 (4)
CHEBI:27632 (4)
CHEBI:28837 (4)
CHEBI:422 (4)
CHEBI:28875 (4)
CHEBI:18257 (4)
CHEBI:16958 (4)
CHEBI:17634 (4)
CHEBI:16865 (4)

Metabolite Name

Putrescine (5)
L-Phenylalanine (5)
Ethanolamine (4)
Diacetone alcohol (4)
Glycine (4)
L-Aspartic acid (4)
Guanosine monophosphate (4)
Stearic acid (4)
L-Proline (4)
Palmitic acid (4)
L-Serine (4)
L-Isoleucine (4)
L-Leucine (4)
L-Tyrosine (4)
Oxalic acid, allyl octadecyl ester (3)
Gamma-Aminobutyric acid (3)
L-Aspartic acid 2 (3)
L-Tyrosine 2 (3)
L-Glutamate 2 (3)
2,6,10,15-tetramethylheptadecane (3)
L-Alanine 2 (3)
L-Isoleucine 2 (3)
Hexadecane 2 (3)
Carbodiimide (3)
Pentasiloxane, dodecamethyl- (3)
Trans-(2,3-Diphenylcyclopropyl)methyl phenyl sulfoxide (3)
Heptacosane 4 (3)
Heptacosane 3 (3)
Heptacosane 2 (3)
1-Iodo-2-methylundecane (3)

Modification

N6-dimethyl-L-lysine (2)
4-tetrahydrothiazine-3-carboxylic acid (1)
N6 (1)

Study type

ChIP-seq (28)
Transcription profiling by array (7)
Unknown experiment type (2)
Methylation profiling by high throughput sequencing (1)

Release Date

2011 (26)
2023 (8)
2020 (8)
2010 (7)
2016 (5)
2022 (5)
2025 (4)
2024 (4)
2021 (4)
2018 (4)
2007 (3)
2008 (2)
2019 (2)
2013 (1)
2009 (1)
2015 (1)
2012 (1)

Lab affiliation

Charles Perkins Centre, School of Medical Sciences, University of Sydney, Sydney, Australia. (3)
Jiangsu Key Laboratory of Crop Genetics and Physiology/Co-Innovation Center for Modern Production Technology of Grain Crops, Key Laboratory of Plant Functional Genomics of the Ministry of Education, Yangzhou University, Yangzhou 225009, China (2)
Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Associate Editor, ACS Chemical Biology (2)
Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Executive Editor, ACS Chemical Biology (2)
West China Second University Hospital, Sichuan University (2)
1Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China 2Academy of Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China 3Synthetic and Functional Biomolecules Center, Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China (1)
Centre for Blood Research, Department of Oral Biological and Medical Sciences, University of British Columbia, Vancouver, BC, Canada (1)
Dana Farber Cancer Institute (1)
Departement for Biomedical Research University of Bern Switzerland (1)
Environmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, California 92521, United States (1)
Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Exceutive Editor, ACS Chemical Biology (lab head) (1)
School of Biosciences University of Sheffield United Kingdom (1)
School of Biosciences, University of Sheffield (1)
School of Biosciences, University of Sheffield. (1)
School of Medical Sciences, Faculty of Medicine and Healthy, University of Sydney, Sydney, Australia. (1)
Shenzhen Key Laboratory of Synthetic Genomics, Guangdong Provincial Key Laboratory of Synthetic Genomics, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China (1)
The University of Sydney (1)
University of Minnesota, Chemistry Department (1)
Weill Cornell Medical College, New York City (1)
shanghai, china (1)

Previous page
1 / 17
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 17
Next page

Sort by:

Relevance

Page size

Brigham and Women's Hospital Multiple Sclerosis Genetic Collection

The main objective of this GWA study is to identify Multiple Sclerosis (MS) susceptibility loci. Whole-genome association analysis was performed on 924 individuals genotyped on the Affymetrix 6.0 Genechip. The cohort consisted of 860 clinically diagnosed MS patients and 64 control subjects.

phs000275.v1.p1 | EGA

OVCAR-3 spheroid-derived cells display distinct metabolic profiles

Recently, multicellular spheroids were isolated from a well-established epithelial ovarian cancer cell line, OVCAR-3, and were propagated in vitro. These spheroid derived cells displayed numerous hallmarks of cancer stem cells, which are chemo and radioresistant cells thought to be a significant cau...

2015-01-08 | MTBLS152 | MetaboLights

GLS1 interactome in liver cells by IP followed by LC-MS/MS

Glutaminase (GLS1) is involved in the development of Alcoholic liver disease (ALD). Protein-protein interactions underlie the biological processes impacted by GLS1. we used immunoprecipitation-mass spectrometry (IP-MS) technology and found the proteins interacted with GLS1.

ORGANISM(S): Homo sapiens (Human)

2025-12-08 | PXD050603 | Pride

Synergistic Repression of Embryonic Program by SET DOMAIN GROUP 8 and EMBRYONIC FLOWER 2 in Arabidopsis Seedlings

The seed maturation program occurs only during late phase of embryo development and repression of the maturation genes is pivotal for seedling development. However, mechanisms that repress the expression of this program in vegetative tissues are not well understood. A genetic screen was performed fo...

ORGANISM(S): Arabidopsis thaliana

2011-12-31 | E-GEOD-29771 | biostudies-arrayexpress

Metabolic Dynamics in Escherichia coli-Based Cell-Free Systems

The field of metabolic engineering has yielded remarkable accomplishments in using cells to produce valuable molecules, and cell-free expression (CFE) systems have the potential to push the field even further. However, CFE systems still face some outstanding challenges, including endogenous metaboli...

2023-02-22 | MTBLS2630 | MetaboLights

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

Not available

S-EPMC4322257 | biostudies-literature

Identification of regulators of polyploidization presents therapeutic targetsfor treatment of AMKL

Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, Bray MA, Thiollier C, Diebold L, Gilles L, Vokes MS, Moore CB, Bliss-Moreau M, Verplank L, Tolliday NJ, Mishra R, Vemula S, Shi J, Wei L, Kapur R, Lopez CK, Gerby B, Ballerini P, Pflumio F, Gilliland DG, Go...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2014-01-27 | MSV000078536 | MassIVE

A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional control in humans and mice

Meiotic recombination ensures proper chromosome segregation and genetic diversity during gametogenesis, and its disruption leads to infertility. It is known that the dual histone methylation writer–reader system, in which PRDM9 deposits H3K4me3 and H3K36me3 marks at nucleosomes to specify recombinat...

ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse)

2026-01-07 | PXD068838 | Pride

Meiotic recombination zcwpw1–zcwpw2 complex prdm9/zcwpw1/zcwpw2 system ldha ep300 lactylation

Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19.